Clinical trial
Study to Determine the Effects of Human Growth Hormone and Pioglitazone in…
NCT00352287 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00352287 |
|---|---|
| Title | Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults |
| Official title | Effects of GH and Pioglitazone in Viscerally Obese Adults With IGT |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Obesity, Metabolic Syndrome, Impaired Glucose Tolerance |
| Intervention type | Drug |
| Interventions | Recombinant human growth hormone, pioglitazone |
| Enrollment | 60 |
| Start date | Mar 1, 2003 |
| Completion | Apr 1, 2005 |
| First posted | Jul 14, 2006 |
| Last update posted | Jul 14, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: